Waltermire Robert E.

CIK 00018769961 companyWEST CONSHOHOCKEN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001876996

Recent Transactions

50 trades

Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$343.85/sh−4,701→ 5,140 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$87.09/sh+7,288→ 17,841 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-03-05−6,825→ 4,375 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$341.84/sh−1,043→ 10,918 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$340.75/sh−1,657→ 11,961 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$338.09/sh−1,146→ 14,018 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-03-05+1,157→ 1,157 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$342.90/sh−1,077→ 9,841 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$336.78/sh−1,777→ 15,164 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$87.92/sh+6,825→ 10,553 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05+2,061→ 5,789 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$344.76/sh−1,412→ 3,728 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$339.68/sh−400→ 13,618 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-03-05−7,288→ 3,062 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-03-05$335.15/sh−900→ 16,941 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-28$340.99/sh−1,052→ 3,903 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-28$341.55/sh−175→ 3,728 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-01-24$335.24/sh−103→ 4,955 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-01-17$273.41/sh−442→ 5,058 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-06-14−1,900→ 10,350 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-06-14$280.00/sh−1,900→ 5,500 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-06-14$87.09/sh+1,900→ 7,400 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-06-12$87.92/sh+2,000→ 7,500 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-06-12$285.00/sh−2,000→ 5,500 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-06-12−2,000→ 15,200 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-05-21$231.34/sh−1,036→ 5,500 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Market Stock Unit
2024-01-23+1,419→ 1,419 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-01-23+1,419→ 6,536 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-01-23+2,138→ 2,138 total
Tax Payment
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-01-16$243.92/sh−550→ 5,117 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-15$236.00/sh−1,000→ 6,667 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-15$87.92/sh+2,000→ 7,667 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-15$241.00/sh−1,000→ 5,667 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2023-12-15−2,000→ 17,200 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-14$87.92/sh+2,000→ 7,667 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-14$233.00/sh−1,000→ 6,667 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-14$232.00/sh−1,000→ 5,667 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2023-12-14−2,000→ 19,200 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-13$87.92/sh+2,500→ 8,167 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-13$226.00/sh−1,000→ 5,667 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-13$225.00/sh−1,500→ 6,667 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2023-12-13−2,500→ 21,200 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-12$216.00/sh−500→ 6,467 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2023-12-12−1,300→ 23,700 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-12$87.92/sh+1,300→ 6,967 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-12-12$219.00/sh−800→ 5,667 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-03-01$87.92/sh+5,000→ 10,667 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-03-01$273.44/sh−1,928→ 8,739 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2023-03-01$275.53/sh−1,300→ 5,767 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2023-03-01−5,000→ 25,000 total

Companies

MADRIGAL PHARMACEUTICALS, INC.
Senior VP, Chief Pharma Dev.
$MDGL

Recent Filings

Address

C/O MADRIGAL PHARMACEUTICALS, INC. 200 BARR HARBOR DRIVE, SUITE 200

WEST CONSHOHOCKEN, PA, 19428

View on SEC.gov